🚀 VC round data is live in beta, check it out!
Momina Krepost Valuation Multiples
Discover revenue and EBITDA valuation multiples for Momina Krepost and similar public comparables like Odinwell, S2Medical, Audientes, Cuprina Holdings (Cayman) and more.
Momina Krepost Overview
About Momina Krepost
Momina Krepost AD is engaged in the production and sales of medical products. The product portfolio includes syringes, injection needles, tubes, catheter, medical clothes, urine collecting bags, among others.
Founded
1966
HQ
Employees
69
Website
Sectors
Financials (FY)
EV
$2M
Momina Krepost Financials
Momina Krepost reported last fiscal year revenue of $680K and negative EBITDA of ($710K).
In the same fiscal year, Momina Krepost generated $177K in gross profit, ($710K) in EBITDA losses, and had net loss of ($1M).
Momina Krepost P&L
In the most recent fiscal year, Momina Krepost reported revenue of $680K and EBITDA of ($710K).
Momina Krepost expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $680K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $177K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 26% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($710K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (104%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (137%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($1M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (156%) | XXX | XXX | XXX |
| Net Debt | — | — | $244K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Momina Krepost Stock Performance
Momina Krepost has current market cap of $2M, and enterprise value of $2M.
Market Cap Evolution
Momina Krepost's stock price is $1.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $2M | 1.0% | XXX | XXX | XXX | $-0.63 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMomina Krepost Valuation Multiples
Momina Krepost trades at 3.3x EV/Revenue multiple, and (3.2x) EV/EBITDA.
Momina Krepost Financial Valuation Multiples
As of April 2, 2026, Momina Krepost has market cap of $2M and EV of $2M.
Equity research analysts estimate Momina Krepost's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Momina Krepost has a P/E ratio of (1.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (3.2x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (2.4x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 12.8x | XXX | XXX | XXX |
| P/E | — | XXX | (1.8x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (10.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Momina Krepost Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Momina Krepost Margins & Growth Rates
Momina Krepost's revenue in the last fiscal year declined by (9%).
Momina Krepost's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Momina Krepost Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (9%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (104%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (1%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 18% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 163% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Momina Krepost Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Odinwell | XXX | XXX | XXX | XXX | XXX | XXX |
| S2Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Audientes | XXX | XXX | XXX | XXX | XXX | XXX |
| Cuprina Holdings (Cayman) | XXX | XXX | XXX | XXX | XXX | XXX |
| Airway Medix | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Momina Krepost M&A Activity
Momina Krepost acquired XXX companies to date.
Last acquisition by Momina Krepost was on XXXXXXXX, XXXXX. Momina Krepost acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Momina Krepost
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMomina Krepost Investment Activity
Momina Krepost invested in XXX companies to date.
Momina Krepost made its latest investment on XXXXXXXX, XXXXX. Momina Krepost invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Momina Krepost
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Momina Krepost
| When was Momina Krepost founded? | Momina Krepost was founded in 1966. |
| Where is Momina Krepost headquartered? | Momina Krepost is headquartered in Bulgaria. |
| How many employees does Momina Krepost have? | As of today, Momina Krepost has over 69 employees. |
| Is Momina Krepost publicly listed? | Yes, Momina Krepost is a public company listed on Bulgarian Stock Exchange. |
| What is the stock symbol of Momina Krepost? | Momina Krepost trades under MKR ticker. |
| When did Momina Krepost go public? | Momina Krepost went public in 1998. |
| Who are competitors of Momina Krepost? | Momina Krepost main competitors are Odinwell, S2Medical, Audientes, Cuprina Holdings (Cayman). |
| What is the current market cap of Momina Krepost? | Momina Krepost's current market cap is $2M. |
| What is the current revenue of Momina Krepost? | Momina Krepost's last fiscal year revenue is $680K. |
| What is the current EV/Revenue multiple of Momina Krepost? | Current revenue multiple of Momina Krepost is 3.3x. |
| Is Momina Krepost profitable? | No, Momina Krepost is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.